Please login to the form below

Not currently logged in
Email:
Password:

sleep disorders

This page shows the latest sleep disorders news and features for those working in and with pharma, biotech and healthcare.

Axovant bets on gene therapy with $842.5m Oxford BioMedica deal

Axovant bets on gene therapy with $842.5m Oxford BioMedica deal

Axovant’s lead candidate now is nelotanserin, a 5-HT2a receptor inverse agonist in phase II trials as a treatment for visual hallucinations and sleep disorders in Lewy body dementia and

Latest news

More from news
Approximately 1 fully matching, plus 9 partially matching documents found.

Latest Intelligence

  • Pharma deals in May 2015 Pharma deals in May 2015

    This has proved to be the case following Teva's purchase of Cephalon in May 2011 for $6.2bn which brought Provigil (modafinil for sleep disorders) into the portfolio. ... The paediatric PRV was issued when Cholbam was approved for the treatment of

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

  • Neurodiversity, ADHD and work: Obstacles and opportunities

    they generally persist through to adulthood, leading to on average worse educational, occupational, economic, social and relationship outcomes,[3] with higher rates of comorbidities such as mood, anxiety and sleep ... Functional impairment and

  • Clark Health Communications unveils new positioning

    in multiple areas of women’s health and in prostate cancer, haemophilia, sleep/breathing disorders, health informatics and medical diagnostic services and UK programmes in mental health, women’s health and

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Say Communications

Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics